Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SYNGENE INTERNATIONAL LTD.

NSE : SYNGENEBSE : 539268ISIN CODE : INE398R01022Industry : Business SupportHouse : Private

BSE680.7511.35 (+1.7 %)

PREV CLOSE ( ) 669.40

OPEN PRICE ( ) 670.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 53224

TODAY'S LOW / HIGH ( )667.15 693.45

52 WK LOW / HIGH ( )598.55 960

NSE681.1011.35 (+1.69 %)

PREV CLOSE( ) 669.75

OPEN PRICE ( ) 667.40

BID PRICE (QTY) 681.10 (4)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3025346

TODAY'S LOW / HIGH( ) 665.70 693.00

52 WK LOW / HIGH ( )599.55 960.6

Select year

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Operational & Financial Ratios

Earnings Per Share (Rs)

12.33

12.69

11.57

9.88

10.12

CEPS(Rs)

23.08

23.28

20.70

17.60

16.99

DPS(Rs)

1.25

1.00

0.00

Book NAV/Share(Rs)

115.46

104.19

88.51

80.09

68.61

Tax Rate(%)

24.81

17.85

21.77

18.29

13.70

Margin Ratios

Core EBITDA Margin(%)

28.49

29.05

29.18

28.43

29.90

EBIT Margin(%)

19.50

19.13

19.98

19.53

22.75

Pre Tax Margin(%)

18.05

17.78

18.57

18.60

21.48

PAT Margin (%)

13.57

14.60

14.53

15.20

18.54

Cash Profit Margin (%)

25.40

26.80

25.99

27.09

31.10

Performance Ratios

ROA(%)

7.71

8.59

8.25

7.69

9.17

ROE(%)

11.23

13.18

13.73

13.29

16.59

ROCE(%)

15.42

15.55

15.43

13.24

15.40

Asset Turnover(x)

0.57

0.59

0.57

0.51

0.49

Sales/Fixed Asset(x)

0.72

0.74

0.76

0.71

0.69

Working Capital/Sales(x)

4.10

4.29

2.58

2.67

3.24

Efficiency Ratios

Fixed Capital/Sales(x)

1.39

1.35

1.31

1.40

1.46

Receivable days

48.32

50.73

59.21

68.92

73.02

Inventory Days

19.66

29.85

29.24

16.75

7.09

Payable days

6521.69

1652.80

-2132.64

-4008.24

-3357.42

Valuation Parameters

PER(x)

58.90

55.31

51.39

60.44

53.68

PCE(x)

31.47

30.14

28.72

33.91

31.99

Price/Book(x)

6.29

6.73

6.72

7.45

7.92

Yield(%)

0.17

0.18

0.21

0.17

0.00

EV/Net Sales(x)

7.84

7.96

7.49

9.29

10.01

EV/Core EBITDA(x)

25.64

25.15

23.78

28.50

29.69

EV/EBIT(x)

40.05

41.60

37.43

47.58

44.00

EV/CE(x)

5.89

6.32

5.70

4.40

4.56

M Cap / Sales

8.02

8.09

7.47

9.19

9.95

Growth Ratio

Net Sales Growth(%)

4.41

9.26

22.61

19.22

8.57

Core EBITDA Growth(%)

0.78

9.92

18.42

15.28

5.28

EBIT Growth(%)

6.74

4.57

25.62

2.33

-9.90

PAT Growth(%)

-2.71

9.82

17.33

-2.25

-1.75

EPS Growth(%)

-2.83

9.66

17.16

-2.44

-1.75

Financial Stability Ratios

Total Debt/Equity(x)

0.03

0.16

0.25

0.28

Current Ratio(x)

1.64

1.71

2.04

1.80

1.59

Quick Ratio(x)

1.53

1.50

1.76

1.65

1.55

Interest Cover(x)

13.43

14.15

14.13

21.10

17.94

Total Debt/Mcap(x)

0.00

0.01

0.02

0.03

0.04